Uncoupling of protein C and antithrombin III activity in cerebral ischemia patients associated with Cutis marmorata

Acta Neurologica Taiwanica

Volumn 17, Issue 4, 2008, Pages 233-238

  Li, Tzu Hui ^a   Chen, Tsung Hwa ^a   Lin, Hung Sheng ^a   Liou, Chia Wei ^a   Liu, Jia Shou ^a   Chen, Shun Sheng ^a   Chen, Wei Hsi ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Antithrombin III; Cerebral ischemia; Cutis marmorata; Protein C; Protein S

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTITHROMBIN III; FIBRINOGEN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; THROMBIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BRAIN RADIOGRAPHY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CUTIS MARMORATA; DISEASE ASSOCIATION; FEMALE; HEMOSTASIS; HUMAN; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; RISK ASSESSMENT; SKIN DISEASE; SKIN EXAMINATION; THROMBOCYTE COUNT; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANTIBODIES, ANTIPHOSPHOLIPID; ANTITHROMBIN III; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; BRAIN ISCHEMIA; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PROTEIN C; PROTEIN S; SKIN DISEASES, VASCULAR; TAIWAN;

EID: 58149305715     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ehrmann S. Ein Gefaessprozess Bei Lues. Wien Med Wochenschr 1907;57:777-82.
2. Bruyn RPM. Sneddon's syndrome. In: Toole JE, ed. Handbook of Clinical Neurology. Vascular Diseases, Part III. Amsterdam: Elsevier Science Publishers B.V., 1989: 401-10.
3. Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol 2006;33:2379-82.
4. Hairston BR, Davis MD, Pittelkow MR, et al. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006;142:1413-8.
5. Englert HJ, Loizou S, Derue GG, et al. Clinical and immunologic features of livedo reticularis in lupus: a case-control study. Am J Med 1989;87:408-10.
6. Francés C, Niang S, Laffitte E, et al. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 2005;52:1785-93.
7. Toubi E, Shoenfeld Y. Livedo reticularis as a criterion for antiphospholipid syndrome. Clin Rev Allergy Immunol 2007;32:138-44.
8. Chen WH, Lin HS, Kao YF, et al. Hyperhomocysteinemia relates to the subtype of antiphospholipid antibodies in non-SLE patients. Clin Appl Thromb Hemost 2007;13:398-403.
9. Chen WH, Kao YF, Lan MY, et al. The increase of blood anticardiolipin antibody depends on the underlying etiology in cerebral ischemia. Clin Appl Thromb Hemost 2006;12: 69-76.
10. Kanda T. Sneddon syndrome. Nippon Rinsho 2004;62:192-5.
11. Zelger B, Sepp N, Schmid KW, et al. Life history of cutaneous vascular lesions in Sneddon's syndrome. Hum Pathol 1992;23:668-75.
12. Garzon MC, Schweiger E. Cutis marmorata telangiectatica congenita. Semin Cutan Med Surg 2004;23:99-106.
13. Seinturier C, Imbert B, Ponard D, et al. Sneddon syndrome with anti-mitochondrial type M5 antibodies. Presse Med 2005;34:1011-2.
14. Kalashnikova LA, Berkovskii AL, Dobrynina LA, et al. Clotting factor VIII in Sneddon syndrome. Klin Med (Mosk) 2003;81:42-5.
15. Khosrotehrani K, Leroy-Matheron C, Mourier C, et al. Sneddon syndrome revealing dysfibrinogenemia. Int J Dermatol 2003;42:561-2.
16. Heughan CE, Kanigsberg N. Cutis marmorata telangiectatica congenita and neonatal lupus. Pediatr Dermatol 2007; 24:320-1.
17. Elahi B, Ramyar A. Hemophagocytic lymphohistiocytosis in a neonate with cutis marmorata telangiectatica congenita. Saudi Med J 2006;27:1751-3.
18. Melani L, Antiga E, Torchia D, et al. Cutis marmorata telangiectatica congenita and chronic autoimmune urticaria in a young man. J Dermatol 2007;34:210-3.
19. Green D, Maliekel K, Sushko E, et al. Activated-protein-C resistance in cancer patients. Haemostasis 1997;27:112-8.
20. Chen WH, Kao YF, Lan MY, et al. A perturbation of antithrombin-III and protein C coupling associates with an increase of anti-beta2-glycoprotein I antibody in non-antiphospholipid antibody syndrome cerebral ischemia. Blood Coagul Fibrinolysis 2002;13:703-9.
21. Vaziri ND, Alikhani S, Patel B, et al. Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome. Nephron 1988;49:20-3.
22. Hooper WC, Phillips DJ, Ribeiro M, et al. IL-6 upregulates protein S expression in the HepG-2 hepatoma cells. Thromb Haemost 1995;73:819-24.
23. Niessen RW, Lamping RJ, Jansen PM, et al. Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons. Thromb Haemost 1997;78:1088-92.
24. Esmon CT. Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? Blood 2000;95:1113-6.
25. Esmon CT. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. Baillieres Best Pract Res Clin Haematol 1999;12:343-59.